Target Name: BMP8A
NCBI ID: G353500
Review Report on BMP8A Target / Biomarker Content of Review Report on BMP8A Target / Biomarker
BMP8A
Other Name(s): bone morphogenetic protein 8a | FLJ14351 | Bone morphogenetic protein 8A | BMP-8A | Bone morphogenetic protein 8a | Bone morphogenetic protein 8A (BMP8A) | FLJ45264 | BMP8A_HUMAN | OP-2

BMP8A: A Versatile Protein with Multiple Functions

Bone morphogenetic protein 8a (BMP8A) is a protein that is expressed in a variety of tissues throughout the body, including bone marrow, fat tissue, and the placenta. It is a member of the BMP family, which includes proteins that are involved in the regulation of cell behavior and cell fate.

BMP8A is a 21-kDa protein that is expressed in a variety of tissues throughout the body. It is highly expressed in bone marrow, where it is involved in the regulation of bone growth and development. It is also expressed in fat tissue and the placenta, where it is involved in the regulation of fat metabolism and fetal development.

One of the key functions of BMP8A is its role in cell-to-cell adhesion. BMP8A is able to interact with a variety of cell surface molecules, including integrins, and this interaction is important for the migration and proliferation of cells.

BMP8A has also been shown to play a role in the regulation of cellular stress responses. It is able to induce a variety of cellular stress responses, including the production of reactive oxygen species (ROS) and the activation of caspases. This regulation of cellular stress responses is important for the maintenance of cellular homeostasis and for the regulation of cellular processes that are necessary for growth and development.

In addition to its role in cell-to-cell adhesion and cellular stress responses, BMP8A has also been shown to play a role in the regulation of cellular signaling pathways. It is able to interact with a variety of signaling molecules, including TGF-β, Wnt, and FGF. This interaction with these signaling molecules is important for the regulation of cellular processes that are necessary for growth and development.

Given the variety of functions that BMP8A has been shown to play, it is likely to be a drug target or biomarker of interest. There is ongoing research into the use of BMP8A as a potential therapeutic agent for a variety of diseases, including cancer, osteoporosis, and neurodegenerative diseases.

One of the potential advantages of using BMP8A as a drug or biomarker is its ability to induce a variety of cellular responses, including cell proliferation, migration, and stress. This makes it a potentially useful agent for the treatment of diseases that are characterized by the over-production or dysfunction of cellular processes.

Another advantage of BMP8A is its ability to be used in a variety of experimental models, including in vitro and in vivo systems. This makes it a useful tool for the study of the functions of BMP8A and its potential role in cellular processes.

Overall, BMP8A is a protein that has a variety of functions in cellular processes, including cell-to-cell adhesion, stress responses, and signaling pathways. Its potential as a drug or biomarker makes it an attractive target for the study of cellular processes and the development of new therapeutic agents.

Protein Name: Bone Morphogenetic Protein 8a

Functions: Induces cartilage and bone formation. May be the osteoinductive factor responsible for the phenomenon of epithelial osteogenesis. Plays a role in calcium regulation and bone homeostasis (By similarity). Signaling protein involved in regulation of thermogenesis and energy balance. Proposed to increase the peripheral response of brown adipose tissue (BAT) to adrenergic stimulation while acting centrally in the hypothalamus to increase sympathetic output to BAT

The "BMP8A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BMP8A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BMP8B | BMPER | BMPR1A | BMPR1B | BMPR1B-DT | BMPR2 | BMS1 | BMS1P1 | BMS1P10 | BMS1P14 | BMS1P15 | BMS1P17 | BMS1P18 | BMS1P2 | BMS1P20 | BMS1P21 | BMS1P22 | BMS1P4 | BMS1P7 | BMS1P8 | BMT2 | BMX | BNC1 | BNC2 | BNC2-AS1 | BNIP1 | BNIP2 | BNIP3 | BNIP3L | BNIP5 | BNIPL | BOC | BOD1 | BOD1L1 | BOD1L2 | BOK | BOK-AS1 | BOLA1 | BOLA2 | BOLA2B | BOLA3 | BOLA3-DT | BOLL | Bombesin receptor | Bone morphogenetic protein (BMP) | Bone Morphogenetic Protein Receptor | Bone Morphogenetic Protein Receptor Type I | BOP1 | BORA | BORCS5 | BORCS6 | BORCS7 | BORCS7-ASMT | BORCS8 | BORCS8-MEF2B | BPESC1 | BPGM | BPHL | BPI | BPIFA1 | BPIFA2 | BPIFA3 | BPIFA4P | BPIFB1 | BPIFB2 | BPIFB3 | BPIFB4 | BPIFB5P | BPIFB6 | BPIFC | BPNT1 | BPNT2 | BPTF | BPY2 | Bradykinin receptor | BRAF | BRAFP1 | Branched-chain alpha-ketoacid dehydrogenase (BCKD) complex | BRAP | BRAT1 | BRCA1 | BRCA1-A complex | BRCA1-BRCA2-containing complex | BRCA1P1 | BRCA2 | BRCC3 | BRD1 | BRD2 | BRD3 | BRD3OS | BRD4 | BRD7 | BRD7P3 | BRD8 | BRD9 | BRDT | BRF1 | BRF2 | BRI3 | BRI3BP